Jason Kelly is the co-founder and CEO of Ginkgo Bioworks, a company at the forefront of synthetic biology. With a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from MIT, Kelly has been instrumental in steering Ginkgo Bioworks towards significant advancements in the life sciences sector. His leadership has been pivotal since the company's inception in 2008.
Who is the CEO of Ginkgo Bioworks?
Jason Kelly, the co-founder and CEO of Ginkgo Bioworks, has been a driving force in the biotechnology industry since the company's inception in 2008. With a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from MIT, Kelly's academic background has been instrumental in shaping Ginkgo Bioworks' mission to harness the power of synthetic biology. His leadership extends beyond Ginkgo, as he also serves as a director of CM Life Sciences II Inc., a special purpose acquisition company focused on the life sciences sector.
Work History
Jason Kelly's work history includes several notable positions:
- Ginkgo Bioworks - Founder (2008 to Present)
- OpenWetWare - Founder (2005 to 2008)
Education History
Jason Kelly's educational journey is rooted in his time at the Massachusetts Institute of Technology (MIT). He earned a B.S. in Biology and Chemical Engineering from MIT, where he studied from January 1999 to January 2003. Following his undergraduate studies, Kelly continued at MIT to pursue a Ph.D. in Biological Engineering, which he completed between January 2003 and January 2008. This extensive academic background has provided him with a solid foundation in both the theoretical and practical aspects of biological and chemical engineering, which has been crucial in his role at Ginkgo Bioworks.
When did Jason Kelly join Ginkgo Bioworks?
Jason Kelly founded Ginkgo Bioworks on August 1, 2008, and has been serving as its CEO since its inception. With his extensive background in biological and chemical engineering, Kelly has been at the helm of the company for over 15 years, driving its mission to harness the power of synthetic biology. His leadership has been a constant since the company's early days, ensuring a steady and visionary approach to the company's growth and innovation.